Gushengtang (02273): Gushengtang Singapore received a $1.6 million investment from Tu Health Care.

GUSHENGTANG (02273) announced that on June 10, 2025, Gushengtang Singapore (a wholly-owned subsidiary of the company) entered into a subscription agreement with Tu Health Care, whereby Tu Health Care agreed to inject S$1.6 million in cash into Gushengtang Singapore. Upon completion of the injection, (i) Gushengtang Singapore will be held by the company and Tu Health Care at approximately 83.16% and 16.84% respectively; and (ii) Gushengtang Singapore will continue to be a subsidiary of the company, with its financial performance consolidated into the group's financial statements. It is reported that Gushengtang Singapore is mainly engaged in research and development, marketing and sales, supply chain services, and operational business support center. As of the date of this announcement, Gushengtang Singapore is a wholly-owned subsidiary of the company and has not engaged in significant business operations. The announcement states that the company intends to designate Gushengtang Singapore as its international business headquarters in Singapore and globally. This strategic move aims to enhance the group's overseas business development capabilities and enable a more focused and effective expansion into international markets. Mr. Tu believes that the injection into Gushengtang Singapore will not only improve its capital structure and support its operational scale growth but also share risks with Gushengtang Singapore, enhance its credibility and attractiveness to external investors, thereby expanding its access to diversified financing channels and laying a solid foundation for future fundraising.